Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 4. RLS spectra of (A) TMPipEOPP and (B) OMHEPzEOPP in the presence of different concentrations of KRAS. The RLS ... Figure 4. RLS spectra of (A)

Published byNiilo Leppänen Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 4. RLS spectra of (A) TMPipEOPP and (B) OMHEPzEOPP in the presence of different concentrations of KRAS. The RLS ... Figure 4. RLS spectra of (A)"— Presentation transcript:

1 Figure 4. RLS spectra of (A) TMPipEOPP and (B) OMHEPzEOPP in the presence of different concentrations of KRAS. The RLS ... Figure 4. RLS spectra of (A) TMPipEOPP and (B) OMHEPzEOPP in the presence of different concentrations of KRAS. The RLS intensity increased first (red lines) and then declined (blue lines) with KRAS concentration. The inserts show the KRAS concentration-dependent changes in the RLS signal intensity at 450 nm. [TMPipEOPP] = [OMHEPzEOPP] = 5 μM. Excitation and emission slits were set at 3 and 1.5 nm, respectively. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Nucleic Acids Res, Volume 47, Issue 6, 04 February 2019, Pages 2727–2738, The content of this slide may be subject to copyright: please see the slide notes for details.

2 Scheme 1. The chemical structures of the four porphyrin derivatives used in this work.
Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Nucleic Acids Res, Volume 47, Issue 6, 04 February 2019, Pages 2727–2738, The content of this slide may be subject to copyright: please see the slide notes for details.

3 Scheme 2. Synthetic route of OMHEPzEOPP.
Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Nucleic Acids Res, Volume 47, Issue 6, 04 February 2019, Pages 2727–2738, The content of this slide may be subject to copyright: please see the slide notes for details.

4 Figure 1. (A, B) UV-vis absorption, (C, D) fluorescent, (E, F) RLS spectra and corresponding signal outputs of ... Figure 1. (A, B) UV-vis absorption, (C, D) fluorescent, (E, F) RLS spectra and corresponding signal outputs of TMPipEOPP in the absence or presence of different DNAs at pH of 7.0. Free porphyrin (black line); ssDNA (green line); dsDNA (blue line); G-quadruplex (red line). The effects of other DNAs were shown in Supplementary Figures S8–S11. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Nucleic Acids Res, Volume 47, Issue 6, 04 February 2019, Pages 2727–2738, The content of this slide may be subject to copyright: please see the slide notes for details.

5 Figure 2. RLS intensity ratio of (A) OMHEPzEOPP, (B) TMPipEOPP, (C) m-TPyEOPP and (D) FA-TMPipEOPP in the absence or ... Figure 2. RLS intensity ratio of (A) OMHEPzEOPP, (B) TMPipEOPP, (C) m-TPyEOPP and (D) FA-TMPipEOPP in the absence or presence of different structural DNAs at pH 7.4, 7.0, 6.5 and 6.0, respectively. ‘0’ represent free porphyrins, and the serial number of DNA is same to that in Table 1. Free porphyrin (black); ssDNAs (green); dsDNAs (blue); G-quadruplexes (red). [porphyrin] = 5 μM; [DNA] = 10 μM. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Nucleic Acids Res, Volume 47, Issue 6, 04 February 2019, Pages 2727–2738, The content of this slide may be subject to copyright: please see the slide notes for details.

6 Figure 3. (A–C) DNA concentration-dependent RLS spectral changes of TMPipEOPP. (A) KRAS (G-quadruplex); (B) CtDNA ... Figure 3. (A–C) DNA concentration-dependent RLS spectral changes of TMPipEOPP. (A) KRAS (G-quadruplex); (B) CtDNA (dsDNA); (C) ssDNA1 (ssDNA). (D–G) DNA concentration-dependent RLS intensity ratio changes of the four porphyrin probes under their individual appropriate pH conditions. [porphyrin] = 5 μM. Excitation and emission slits were both set at 3 nm. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Nucleic Acids Res, Volume 47, Issue 6, 04 February 2019, Pages 2727–2738, The content of this slide may be subject to copyright: please see the slide notes for details.

7 Figure 5. The result of LDA for (A) OMHEPzEOPP, (B) TMPipEOPP, (C) m-TPyEOPP and (D) FA-TMPipEOPP in the absence or ... Figure 5. The result of LDA for (A) OMHEPzEOPP, (B) TMPipEOPP, (C) m-TPyEOPP and (D) FA-TMPipEOPP in the absence or presence of different structural DNAs at pH 7.4, 7.0, 6.5 and 6.0, respectively. ssDNA and dsDNA (yellow); G-quadruplex (purple). Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Nucleic Acids Res, Volume 47, Issue 6, 04 February 2019, Pages 2727–2738, The content of this slide may be subject to copyright: please see the slide notes for details.

8 Figure 6. Let-7a detection using TMPipEOPP as RLS probe
Figure 6. Let-7a detection using TMPipEOPP as RLS probe. (A) Working mechanism of the sensing platform. (B) RLS spectra ... Figure 6. Let-7a detection using TMPipEOPP as RLS probe. (A) Working mechanism of the sensing platform. (B) RLS spectra of the sensing solutions in the presence of different concentrations of Let-7a. (C) Let-7a concentration-dependent changes in RLS intensity ratio of I<sub>702</sub>/I<sub>652</sub>. The insert shows the linear relationship between I<sub>702</sub>/I<sub>652</sub> value and Let-7a concentration in the range of 0–3.0 μM. [TMPipEOPP] = 5 μM. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Nucleic Acids Res, Volume 47, Issue 6, 04 February 2019, Pages 2727–2738, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "Figure 4. RLS spectra of (A) TMPipEOPP and (B) OMHEPzEOPP in the presence of different concentrations of KRAS. The RLS ... Figure 4. RLS spectra of (A)"

Similar presentations

J Exp Bot. 2017;68(17): doi: /jxb/erx352

J Exp Bot. 2017;68(17): doi: /jxb/erx352
From: Introducing the PRIDE Archive RESTful web services

From: Introducing the PRIDE Archive RESTful web services
Figure 1. The flow chart illustrates the construction process of anti-CRISPRdb, and the information that users can obtain from anti-CRISPRdb. From: Anti-CRISPRdb:

Figure 1. The flow chart illustrates the construction process of anti-CRISPRdb, and the information that users can obtain from anti-CRISPRdb. From: Anti-CRISPRdb:
Figure 1: Necrobiosis lipoidica: Yellow-brown skin lesions with indurated borders located on both lower legs. Figure 1: Necrobiosis lipoidica: Yellow-brown.

Figure 1: Necrobiosis lipoidica: Yellow-brown skin lesions with indurated borders located on both lower legs. Figure 1: Necrobiosis lipoidica: Yellow-brown.
Figure 1. Circular taxonomy tree based on the species that were sequenced in our study. Unless provided in the caption above, the following copyright applies.

Figure 1. Circular taxonomy tree based on the species that were sequenced in our study. Unless provided in the caption above, the following copyright applies.
Figure 1. An example of a thioviridamide-like molecule, thioalbamide, and inset, a proposed biochemical route to ... Figure 1. An example of a thioviridamide-like.

Figure 1. An example of a thioviridamide-like molecule, thioalbamide, and inset, a proposed biochemical route to ... Figure 1. An example of a thioviridamide-like.
Figure 1. A novel image analysis tool to monitor epigenetic changes in spatiotemporal distribution of chromatin in live ... Figure 1. A novel image analysis.

Figure 1. A novel image analysis tool to monitor epigenetic changes in spatiotemporal distribution of chromatin in live ... Figure 1. A novel image analysis.
Figure 1. Overview of the workflow of NetworkAnalyst 3.0.

Figure 1. Overview of the workflow of NetworkAnalyst 3.0.
Figure 1 The study area within Vienna Zoo is outlined in red

Figure 1 The study area within Vienna Zoo is outlined in red
Figure 4. (A) Venn diagram showing the overlap of peaks differentially changed in DHT as compared to NT with peaks ... Figure 4. (A) Venn diagram showing.

Figure 4. (A) Venn diagram showing the overlap of peaks differentially changed in DHT as compared to NT with peaks ... Figure 4. (A) Venn diagram showing.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1. Aminoacylation of 3′-NH2-tRNA catalyzed by flexizymes

Figure 1. Aminoacylation of 3′-NH2-tRNA catalyzed by flexizymes
Figure 1. Effect of random T/A→dU/A substitutions on transcription by T7 RNAP using a 321 bp DNA transcription template ... Figure 1. Effect of random.

Figure 1. Effect of random T/A→dU/A substitutions on transcription by T7 RNAP using a 321 bp DNA transcription template ... Figure 1. Effect of random.
FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.

FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.
FIGURE 1 The effect of daprodustat on hemoglobin (Hgb) levels

FIGURE 1 The effect of daprodustat on hemoglobin (Hgb) levels
Figure 1 The process of bone defect creation, implant insertion and ridge augmentation. (a) Creation of standardized ... Figure 1 The process of bone defect.

Figure 1 The process of bone defect creation, implant insertion and ridge augmentation. (a) Creation of standardized ... Figure 1 The process of bone defect.
FIGURE 2 Responses to the question: regarding vasoactive drugs, does your centre use the following frequently, rarely ... FIGURE 2 Responses to the question:

FIGURE 2 Responses to the question: regarding vasoactive drugs, does your centre use the following frequently, rarely ... FIGURE 2 Responses to the question:
FIGURE 1 Maternal (A) urinary aldosterone; (B) plasma active renin; (C) urinary AGT concentrations; and (D) plasma AGT ... FIGURE 1 Maternal (A) urinary.

FIGURE 1 Maternal (A) urinary aldosterone; (B) plasma active renin; (C) urinary AGT concentrations; and (D) plasma AGT ... FIGURE 1 Maternal (A) urinary.
Figure 1. Ratios of observed to expected numbers of exon boundaries aligning to boundaries of domain and disorder ... Figure 1. Ratios of observed to expected.

Figure 1. Ratios of observed to expected numbers of exon boundaries aligning to boundaries of domain and disorder ... Figure 1. Ratios of observed to expected.
Figure 1. autoMLST workflow depicting placement and de novo mode

Figure 1. autoMLST workflow depicting placement and de novo mode

Similar presentations

Ads by Google